Technical Bulletins and Memos
- Anti-Factor Xa Assay for Monitoring Unfractionated Heparin, March 2019
- A1c Hemoglobin Assay, Revised, September 2019
- Atellica Reference Ranges, February 2022
- Atellica Test Bulletin, February 2022
- B-Type Natriuretic Peptide (BNP), February 2022
- Biotin Interference, Chemistry Tests Susceptible to, October 2018
- Cancer Antigen CA19-9 and CA15-3 Assays, Method Change, May 2018
- Carcinoembryonic Antigen (CEA) and Cancer Antigen 125 (CA-125) Assays, Method Change for, July 2018
- Clinitest for Reducing Substances in Urine and Stool, Discontinuation of, April 2020
- CP-CRE Notification Memo, January 2018
- Cryptosporidium/Giardia Testing, July 2018
- Diarrhea, Improved Diagnosis Using a Molecular Method, October 2018
- Extragenital Chlamydia and GC Testing, New Service, January 2020
- Group A Strep (GAS) Testing in Pharyngeal Specimens, New PCR assay; Discontinuation of the GAS Antigen Test (BSAA), March 2019
- Hemoglobin A1C: Change in Methodology, June 2018
- HIV 1/2 Screen, Update to, April 2018
- Legionella and Pneumocystis Testing, July 2018
- Lipase, February 2022
- Pertussis, New PCR Test Requiring New Specimen Collection Device, January 2019
- Prostate Specific Antigen (Total & Free) Assays, Method Change for, February 2018
- Rapid HIV Reporting and Algorithm Changes, January 2019
- RSV Memo, January 2018
- SARS-CoV-2 (COVID-19) IgG Antibody - Qualitative Assay June 2020 (In-house)
- SARS-Co-V-2 (COVID-19) IgG Antibody - Qualitative Assay May 2020 (ARUP)
- Tacrolimus by LC/MS/MS, January 2019
- Testosterone by LC/MS/MS and Associated Batteries, January 2019
- Thyroid Cascade, January 2018
- Timed Cortisol Collections, Update to Order Coders, May 2018
- Urine Culture Result Reporting, Changes in, May 2018